65th Indian Pharmaceutical Congress 2013, Delhi NCR to kickstart tomorrow

Read more

Sandoz begins phase III clinical trial for biosimilar adalimumab

Read more

Merck enters into license agreement with Spanish National Cancer Research Centre

Read more

Indegene and DrugLogic to offer full lifecycle drug monitoring

Read more

Biotechnology to propel India’s second green revolution: CII Conference on Agri-Biotechnology

Read more

Lupin launches generic Trizivir tabs

Read more

Biocon inks licensing pact with US-based Quark Pharma

Read more

SPARC receives US FDA response on Venlafaxine NDA

Read more

Indegene launches complete range of MCM services

Read more

StelisBiopharma and Pieris Forge alliance for Novel Anticalin Therapeutics in ophthalmology

Read more